Our technology allows gene control based on cell identity, ensuring only the target cell population is active
By identifying key genomic signatures of cell state, we can generate programmable engineered cells that change their activity in response to the cell environment or condition
We are able to control gene expression with unparalleled precision - dialling expression to the exact level needed for the desired application - no more, no less
Our unique engineering approach allows for dynamic changes in gene control, responding to intra or extracellular cues, and ensuring activity only when needed
Acts only where and when it matters.
Our therapies are programmed to respond to the cell’s unique environment, activating only in the right context.
Multiplex engineering for maximum impact.
Our in-depth understanding of gene regulation enables the development of more effective medicines, facilitating multiplex engineering and addressing key challenges limiting broader adoption of advanced therapies.
Beyond on/off – adaptive, fine-turned gene control.
Our platforms allow precise control over gene expression levels across multiple targets. This tunability makes therapies more effective, responsive, and safer for dynamic and dosage sensitive applications.
Works with the cell, not against it.
Our technology integrates seamlessly with the target cell delivering improved safety and favourable regulatory profiles.
Our technology platforms have broad potential to transform additional therapeutic and non-Tx applications, beyond our internal advanced therapy pipeline. Our partnering strategy aims to maximise value through outlicensing and collaborative partnerships.
